MediWound (MDWD) Income from Continuing Operations (2013 - 2025)
MediWound's (MDWD) quarterly Income from Continuing Operations came in at 7727000.0 in Q4 2025, down 27.03% year-on-year from 10588722.91 in Q4 2024, and down 19.39% quarter-over-quarter from 6472000.0 in Q3 2025.
MediWound (MDWD) Income from Continuing Operations (2013 - 2025) Analysis & Trends
MediWound's Income from Continuing Operations history runs 13 years deep, the most recent figure standing at 7727000.0 for Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 27.03% year-over-year to 7727000.0 in Q4 2025; TTM through Dec 2025 was 32661000.0, a 54.34% decrease from a year earlier, with the FY2025 full-year figure at 23731000.0, up 21.31% from the prior year.
- Income from Continuing Operations slipped to 7727000.0 in Q4 2025 per MDWD's latest filing, from 6472000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 940000.0 in Q2 2023 and bottomed at 13242000.0 in Q2 2025.
- The 5-year median for Income from Continuing Operations is 4170500.0 (2021), against an average of 4655450.0.
- Across the five-year window, Income from Continuing Operations soared 121.63% in 2023 and sank 771.17% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 4152000.0 in 2021, then slumped by 76.47% to 7327000.0 in 2022, then jumped by 79.49% to 1503000.0 in 2023, then tumbled by 304.72% to 6083000.0 in 2024, then slipped by 27.03% to 7727000.0 in 2025.
- Per Business Quant, the three latest MDWD Income from Continuing Operations figures stand at 7727000.0 (Q4 2025), 6472000.0 (Q3 2025), and 13242000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | -7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.73 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Jun 30, 2025 | -13.24 Mn |
| Mar 31, 2025 | -5.22 Mn |
| Dec 31, 2024 | -6.08 Mn |
| Sep 30, 2024 | -5.06 Mn |
| Jun 30, 2024 | -6.31 Mn |
| Mar 31, 2024 | -3.71 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | 940,000.00 |
| Mar 31, 2023 | -3.68 Mn |
| Dec 31, 2022 | -7.33 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.35 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -3.34 Mn |
| Jun 30, 2021 | -3.16 Mn |
| Mar 31, 2021 | -2.85 Mn |